Universite de Lausanne
24Patents
19Active
24Granted
49Portfolio score
Filing activity: Mar 4, 1998 → Aug 18, 2020 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6960648B2 | Intracellular delivery of biological effectors | Chemistry; Metallurgy | 102 | Expired |
| US8318898B2 | Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation | Human Necessities | 56 | Active |
| US6792302B2 | Method and apparatus for determining treatment for stroke | Human Necessities | 25 | Expired |
| US8617180B2 | Adjustable stereotactic device and method for frameless neurosurgical stereotaxy | Human Necessities | 11 | Active |
| US7580737B2 | Method and apparatus for determining treatment for stroke | Human Necessities | 8 | Expired |
| US7033597B2 | Intracellular delivery of biological effectors | Emerging Cross-Sectional Technologies | 5 | Expired |
| US8716443B2 | Sub-region of a plasmodium protein with improved vaccine potential, and medical uses thereof | Emerging Cross-Sectional Technologies | 5 | Active |
| US10815310B2 | Multispecific antigen binding fragments and multispecific antibodies derived therefrom comprising mutant CH1 and CL-kappa domains | Chemistry; Metallurgy | 3 | Active |
| US9631031B2 | Multispecific antigens binding fragments and multispecific antibodies derived therefrom comprising mutant CH1 and CL-κ domains | Chemistry; Metallurgy | 3 | Active |
| US8496937B2 | Preparation of isolated agonist anti-EDAR monoclonal antibodies | Chemistry; Metallurgy | 2 | Active |
| US10858626B2 | Adoptive immunotherapy for treating cancer | Chemistry; Metallurgy | 1 | Active |
| US12378325B2 | Multispecific antigens binding fragments and multspecific antibodies | Chemistry; Metallurgy | 0 | Active |
| US6074875A | Materials and methods relating to the regulation of polypeptide production in cells | Chemistry; Metallurgy | 0 | Expired |
| US12297276B2 | Anti-TEM1 antibodies and antigen-binding portions thereof | Chemistry; Metallurgy | 0 | Active |
| US8741297B2 | Preparation of isolated agonist anti-EDAR monoclonal antibodies | Chemistry; Metallurgy | 0 | Active |
| US8110544B2 | RasGAP derived peptide for selectively killing cancer cells | Chemistry; Metallurgy | 0 | Active |
| US12167731B2 | Fungicides to prevent and control fungal pathogens | Human Necessities | 0 | Active |
| US10526412B2 | Anti APRIL (a proliferation-inducing ligand) antibodies and their uses for the prognosis and/or diagnosis of cancer | Chemistry; Metallurgy | 0 | Active |
| US11738049B2 | Kinase mutants and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US8975370B2 | Inhibitor proteins of a protease and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11193171B2 | Diagnostic, prognostic and therapeutic uses of long noncoding RNAS for heart disease and regenerative medicine | Chemistry; Metallurgy | 0 | Active |
| US10506368B1 | Method and a system for matching subscriptions with publications | Electricity | 0 | Active |
| US12104078B2 | Insect corneal type nanocoatings | Performing Operations; Transporting | 0 | Active |
| US8644905B2 | Magnetic resonance imaging | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.